. 12/2018: Our new 5-year NCI R01 grant regarding DNA methylation canyon was funded.
. 07/2018: Jianzhong's DNA methylation canyon paper was accepted to Genome Biology.
. 06/2018: Jiejun’s paper was accepted to Nature Cell Biology.
. 06/2018: Xueqiu's DNMT3A binding paper was accepted to Genome Biology
. 03/2018: HJ Park's papers were accepted to PLOS Computational Biology and Cell Reports, respectively.
. 01/2018: HJ Park's 3'UTR vs ceRNA paper was finally accepted to Nature Genetics after 1.5 years and 3 rounds of revisions/appeals. A good start of the new year!
. 12/2017: Jiejun and Jie's collaborative papers with Xiaobing Shi were accepted to Genes & Development and Nature Communications, respectively
. 09/2017: Feng Xin and Lei Li's paper on TC3A: The Cancer 3’ UTR Atlas was accepted to Nucleic Acids Research.
. 09/2017: Hyun Jung Park has been offered a tenure-track Assistant Professor position at University of Pittsburgh Medical Center. Congratulations.
. 08/2017: Xueqiu's scUMC DNA methylation paper was accepted to Genome Biology.
. 07/2017: Jianzhong's DNA methylation editing papers with the Goodell lab were published in Nature Communications and Genome Biology.
. 05/2017: Our TCGA Liver Cancer paper was accepted to Cell.
. 02/2017: Our Research Center for Cancer Systems Biology (CCSB U54) grant was funded by NCI, in collaboration with Qianben Wang, Victor Jin and Tim Huang.
. 02/2017: Collaborative work with Xiaobing Shi and David Allis was accepted to Nature.
. 12/2016: Graduate student Xueqiu Lin will start his postdoc position at Stanford.
. 11/2016: Jianfeng Xu has passed his qualify exam. Congratulations!
. 08/2016: Welcome our new Postdoc Associates Drs. Xiaodong Cui, Jiejun Shi and Lei Li.
. 08/16: Zheng Xia will start his tenure-track faculty position at Oregon Health & Science University (OHSU) with a million-dollar package. Congratulations!
. 07/16: Wei has been promoted to Professor of Bioinformatics at Baylor College of Medicine.
. 06/16: Xueqiu successfully defended her PhD thesis. Congratulations Dr. Lin.
. 06/16: A new paper w/ MG Lee @ MD Anderson was accepted to Molecular Cell.
. 04/16: Jianzhong's DNMT3A/TET2 paper (w/ Goodell lab) was accepted to Nature Genetics.
. 04/16: Wei has been selected as a recipient of the 2016 Michael E. DeBakey, M.D., Excellence in Research Award
. 04/16: Yuanxin has been offered a tenure-track faculty position at The University of Texas Health Science Center at Houston (UTHealth). Congratulations!
. 03/2016: Ben's enhancer hypomethylation paper (w/ Goodell lab) was accepted to Cancer Cell.
. 02/2016: Yuanxin's SIRT6 paper (w/ Chua lab at Stanford) was accepted to Nature Structural & Molecular Biology
. 01/2016: Welcome our new Postdoc Associate Dr. Jie Lyu.
. 12/2015: Yuanxin's G9a paper (w/ Shi lab at MD Anderson) was accepted to Nature Communications.
. 12/2015: Kaifu's UTX paper (w/ Lee lab at MD Anderson) was accepted to Nucleic Acids Research .
. 11/2015: We received a new NIH/NCI R01 grant (scored at 5%ile) to study 3`UTR alternations in human cancers.
. 09/2015: Welcome our new Research Associate (and potential Graduate Student) YanBing Cheng.
. 08/2015: Kaifu's Cancer Big-data analysis paper is published in Nature Genetics. This work links broad H3K4me3 to pan-cancer tumor suppressors. See reports in Nature Editor’s Blog, Cancer Discovery, ebiotrade.com (in Chinese), BCM news and OSU news; and an error we found in a Cell paper.
. 07/2015: Wei will become a regular member of the NIH GCAT (Genomics, Computational Biology and Technology) study section.
. 06/2015: Kaifu will start his tenure-track faculty position at Cornell University & Methodist Hospital. Congratulations!
. 03/2015: Kaifu's MeCP2 mCH binding paper (w/ Zoghbi lab) is accepted to PNAS.
. 3/2015: We received a NEW CPRIT grant.
. 01/2015: Deqiang, HJ and Ben's HSC novel noncoding RNA paper is accepted to Cell Stem Cell -- the 100th paper we published.